GlobeNewswire 11/4/2021 Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress
GlobeNewswire 11/2/2021 Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strate...
GlobeNewswire 10/12/2021 Moderna, VIA and Benchling Receive “Tell Awards” for FDI in Switzerland
GlobeNewswire 10/6/2021 Recro Reports Inducement Grants For New Staff
GlobeNewswire 9/24/2021 Capricor Therapeutics Announces Positive Final Data From its Phase 2 HOPE-2 Trial in Patients with D...
GlobeNewswire 9/8/2021 Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment o...
GlobeNewswire 8/24/2021 Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell ...
GlobeNewswire 8/17/2021 Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corpora...
GlobeNewswire 8/11/2021 Vaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire 8/10/2021 Acer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update
GlobeNewswire 7/20/2021 Arbor Strengthens Focus on Therapeutics with Key Additions to Leadership Team
GlobeNewswire 6/21/2021 Arbor Biotechnologies to Present at the Raymond James Human Health Innovation Conference
GlobeNewswire 6/2/2021 Arbor Biotechnologies to Present at the Evercore ISI GenomeRx Emerging Therapeutics Conference and t...
GlobeNewswire 5/27/2021 Arbor Continues to Build Therapeutic Focus with Key Scientific Leaders
GlobeNewswire 5/17/2021 Gracell Biotechnologies Reports First Quarter 2021 Unaudited Financial Results and Provides Corporat...
GlobeNewswire 5/17/2021 Altimmune Announces First Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire 5/13/2021 Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 5/13/2021 aTyr Pharma Announces First Quarter 2021 Results and Provides Corporate Update
GlobeNewswire 5/3/2021 Affinia Therapeutics Closes $110 Million Series B Financing
GlobeNewswire 4/14/2021 aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
GlobeNewswire 4/1/2021 Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
GlobeNewswire 3/12/2021 Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
GlobeNewswire 3/11/2021 Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corpo...
GlobeNewswire 3/3/2021 Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
GlobeNewswire 2/25/2021 Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results